GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioNote Inc (XKRX:377740) » Definitions » Net Interest Income

BioNote (XKRX:377740) Net Interest Income : ₩19,770 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is BioNote Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. BioNote's net interest income for the three months ended in Sep. 2024 was ₩4,989 Mil. Its net interest income for the trailing twelve months (TTM) ended in Sep. 2024 was ₩19,770 Mil.

BioNote Net Interest Income Historical Data

The historical data trend for BioNote's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNote Net Interest Income Chart

BioNote Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Interest Income
-424.43 -135.07 828.57 9,630.43 24,027.00

BioNote Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,624.08 4,394.44 5,510.25 4,875.97 4,989.49

BioNote Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩19,770 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioNote Net Interest Income Related Terms

Thank you for viewing the detailed overview of BioNote's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNote Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioNote Inc (XKRX:377740) » Definitions » Net Interest Income
Comparable Companies
XKRX:335890 XKRX:340570 XKRX:290650 XKRX:099190 XKRX:336570 XKRX:206640 XKRX:041830 XKRX:445680 XKRX:043150 XKRX:060280 ABT SYK BSX MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH
Traded in Other Exchanges
N/A
Address
22, Samsung 1-ro 4-gil, Gyeonggi-do, Hwaseong-si, KOR
Website
https://www.bionote.co.kr
BioNote Inc is a manufacturer of diagnostic kits and equipment for animal diseases and is equipped with a wide product portfolio, from initial screening tests to molecular diagnosis. Its animal diagnostics products comprise of Vcheck F, Vcheck M, Vcheck C, Rapid, and ELISA.

BioNote Headlines

No Headlines